학술논문
Initial Safety and Feasibility Results From a Phase 1, Diagnose-and-Treat Trial of Neoadjuvant Intratumoral Cisplatin for Stage IV NSCLC
Document Type
Short Communication
Author
Source
In JTO Clinical and Research Reports March 2024 5(3)
Subject
Language
ISSN
2666-3643